Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder

Björnsson, M; Acharya, C; Strandgården, K; Tiberg, F

Tiberg, F (通讯作者)，Camurus AB, Lund, Sweden.

CLINICAL PHARMACOKINETICS, 2023; 62 (10): 1427

Abstract

Background and ObjectiveIn treating opioid use disorder (OUD), subcutaneous (SC) extended-release buprenorphine (BPN) depots, e.g., CAM2038, have been......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索